| Substrates, co-substrates, and additives (stock concentration) | Final concentration | Volume to add to 1 mL assay media | |
|---|---|---|---|
| ADP | ADP (0.5M), pH 7.2 in H2O | 4 mM | 8 μL |
| Fatty-acid free BSA | BSA [10% (w/v)] in H2O | 0.2% (w/v) | 20 μL |
| rPFO | rPFO; commercially XF PMP (10 μM) | 1–3 nM | 0.1–0.3 μL |
| NADH-linked (Complex I) substrates | Pyruvate (0.5M), pH 7.2 in H2O Malate (0.5M), pH 7.2 in H2O |
5 mM 0.5 mM |
10 μL 1 μL |
| Glutamate (0.5M), pH 7.2 in H2O Malate (0.5M), pH 7.2 in H2O |
5 mM 5 mM |
10 μL 10 μL |
|
| Palmitoyl CoA (10 mM) in H2O Malate (0.5M) in H2O Carnitine (0.5M) in H2O |
40 μM 0.5 mM 0.5 mM |
4 μL 1 μL 1 μL |
|
| Palmitoyl carnitine (10 mM) in EtOH Malate (0.5M) |
40 μM 0.5 mM |
4 μL 1 μL |
|
| Q-linked (Complex II or III) substrates | Succinate (0.5M), pH 7.2 in H2O Rotenone (2 mM) in EtOH |
5 mM 2 μM |
10 μL 1 μL |
| Glycerol-3-phosphate (0.25M), pH 7.2 in H2O Rotenone (2 mM) in EtOH CaCl2 (1M) in H2O |
5 mM 2 μM 700 μM total |
20 μL 1 μL 0.7 μL |
|
| Complex IV substrates | Ascorbate (1M), pH 7.2 in H2O TMPD (10 mM) Antimycin A (2 mM) |
10 mM 100 μM 1 μM |
10 μL 1 μL 0.5 μL |